Posts in tag

GSK


Last month, Médecins Sans Frontières (MSF) surprised Pfizer by refusing a donation of one million doses of the company’s pneumonia vaccine With high numbers of children who are not immunised against …

Australian Pharmaceutical Industries Limited has named GSK as Supplier of the Year, at API’s annual Supplier Excellence Awards in Melbourne. API’s CEO and MD, Stephen Roche, said that GSK’s continuous …

Panadol Osteo pricing statement ambiguous, but not false or misleading: ACCC  The Australian Competition and Consumer Commission has concluded its investigation into whether GlaxoSmithKline (GSK) made misleading statements about a …

The not-for-profit vehemently denies claims by leading medical publication that it has “sold its soul to big pharma” CEO Dr Lynn Weekes has written a lengthy letter hitting back at …

The pharmaceutical giant was ranked first for its “unmatched record for balancing scientific progress, social impact and the profit motive” Fortune magazine and a panel of experts recently named GlaxoSmithKline the …

The impact of hayfever on quality of life is often underestimated, says one expert. Dr Mimi Tang, allergy specialist at the Murdoch Children’s Research Institute, told the AJP that even …

Initial claims have been dismissed, but there is an opportunity to make further submissions on both sides GlaxoSmithKline’s legal proceeding against Apotex and Generic Partners over its paracetamol products has …

GSK Australia is partnering with the Australian Government to provide a quadrivalent influenza vaccine for the National Immunisation Program for the 2016 season. Fluarix® Tetra is a four-strain flu vaccine …

The Australian Competition and Consumer Commission says it won’t oppose GlaxoSmithKline’s and Novartis’ transactions involving over-the-counter consumer products, human vaccines and oncology products. As a result of the transactions: GSK …

META, a collaborative network of manufacturing businesses and researchers, today announced a collaborative project between Hospira, GlaxoSmithKline and CSL to generate a targeted 3% productivity boost with an estimated return …